NCT06330623

Brief Summary

The aim of this observational study is to translate the principle of individualised exercise prescription into the evaluation of daily absolute and relative intensity physical activity. The main questions this study aims to answer are:

  • Phase 1: What does physical activity (intensity) mean to people with COPD?
  • Phase 2: Are there differences between time spent in absolute and relative physical activity for people with COPD? Phase 1 Participants will take part in semi-structured interview (30-45 minutes) about living with COPD and perceptions of physical activity and how they perceive intensity. This will also include photovoice and photo-elicitation. Demographic information will be recorded and participants will also complete several respiratory symptom questionnaires. Phase 2: Participants will take part in physical activity testing before and after pulmonary rehabilitation while wearing physical activity monitors. Demographic information will be recorded and participants will also complete several respiratory symptom and physical activity questionnaires. Participants will also wear the physical activity monitors for 8 days after the pre-testing sessions and after their final pulmonary rehabilitation class. Sub-study: Participants will be asked to take images of barriers during physical activity, facilitators during physical activity, feelings during physical activity and types of physical activity they take part in for 8 days after their final pulmonary rehabilitation class. Participants will then take part in a semi-structured interview about the images their have taken while doing physical activity.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Nov 2023

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 22, 2023

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

March 4, 2024

Completed
22 days until next milestone

First Posted

Study publicly available on registry

March 26, 2024

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2025

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2025

Completed
Last Updated

September 19, 2024

Status Verified

September 1, 2024

Enrollment Period

1.4 years

First QC Date

March 4, 2024

Last Update Submit

September 11, 2024

Conditions

Keywords

Absolute IntensityActivity MonitorsChronic Obstructive Pulmonary DiseaseExercise CapacityPhysical ActivityRelative Intensity

Outcome Measures

Primary Outcomes (2)

  • Phase 1 - Semi-structured Interviews

    Semi-structured interview with individuals with COPD

    30-45 minutes

  • Phase 2 - Differences between time spent in PA intensity expressed in absolute and relative intensity.

    Differences between time spent in PA intensity expressed in absolute and relative using activity monitors (wrist and waist) for eight days before and after the PR programme.

    8 days

Secondary Outcomes (12)

  • Phase 1 - Medical Research Council (MRC) Dyspnoea Scale

    2 minutes

  • Phase 1 - COPD Assessment Test (CAT)

    5 minutes

  • Phase 1 - Chronic Respiratory Questionnaire (CRQ-SR)

    5 minutes

  • Phase 1 - Photovoice and photo-elicitation

    7 days

  • Phase 2 - Medical Research Council (MRC) Dyspnoea Scale

    2 minutes

  • +7 more secondary outcomes

Study Arms (2)

Phase 1 Cohort

These participants will be recruited from: * Previous research studies * COPD nursing ward * Pulmonary rehabilitation

Phase 2 Cohort

These participants will be recruited from the pulmonary rehabilitation service.

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Phase 1: Patients from the COPD nursing ward, previous research studies and pulmonary rehabilitation programme. Phase 2: Patients from the pulmonary rehabilitation programme.

You may qualify if:

  • Willing and able to provide informed consent for participation in the research.
  • The patient has a confirmed diagnosis of COPD using spirometry (based on GOLD criteria (Agustí et al., 2023).
  • Male or female, aged 40+ years
  • Able to communicate in written and spoken English.

You may not qualify if:

  • Unable to provide valid informed consent.
  • Severe psychiatric disorders
  • Aged less than 40 years
  • Unable to understand written or spoken English.
  • Phase 2:
  • Willing and able to provide informed consent for participation in the research.
  • The patient has a confirmed diagnosis of COPD using spirometry (based on GOLD criteria.
  • The patient is referred for PR at the UHL.
  • Male or female, aged 40+ years
  • Able to communicate in written and spoken English
  • Unable to provide valid informed consent.
  • Lack of motivation to participate in PR programme.
  • Any-contra-indications absolute or relative to exercise training.
  • Has had a cardiac event within last 6 weeks
  • Severe psychiatric disorders
  • +3 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

NIHR Leicester Biomedical Research Centre - Respiratory

Leicester, Leicestershire, LE67 2DU, United Kingdom

RECRUITING

MeSH Terms

Conditions

Pulmonary Disease, Chronic ObstructiveMotor Activity

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsBehavior

Study Officials

  • University of Leicester University of Leicester

    University of Leicester

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Phoebe H Lloyd-Evans

CONTACT

Mark W Orme

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 4, 2024

First Posted

March 26, 2024

Study Start

November 22, 2023

Primary Completion

March 30, 2025

Study Completion

September 1, 2025

Last Updated

September 19, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

The data will only be available in publications.

Locations